Looking to publish in Immunotargets And Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowImmunoTargets and Therapy is an international open access journal that publishes basic and clinical research on immunology in health and disease, with a focus on the biology of the immune system, immune-based therapies, the immunological basis of disease, and the evidence behind new and existing immunotherapies. Specific topics include immune system biology and pathophysiology, immunological markers of disease, targets for immune-based therapy, immunodiagnostics and immunomonitoring, treatment protocols for immune-mediated diseases, management programs and therapeutic agents, and patient-centered outcomes such as quality of life, adherence, and satisfaction.
Looking to publish in Immunotargets And Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Immunotargets And Therapy accepts the following article types. Click on an article type to view submission instructions.
Clinical Trial Report
Original Research
Registered Report
Review
Case Report
Case Series
Letter To The Editor
Rapid Communication
Research Letter
Short Report
Meeting Report
Recent Publications
An Exploratory in vitro Study of Cytotoxicity and Cytokine Profiling of Cytokine-Induced Killer (CIK) Cells Against HCT-15 Colorectal Cancer (CRC) Cells
Sze-Piaw Chin, Natasha Najwa Nor Arfuzir, Vivian Wai-Ping Kong, Soon-Keng Cheong
Development of an Active Chimeric IL13Rα2 ADC for Diffuse Intrinsic Pontine Glioma
Xiaolei Lian, Victoria Allanson, Samuel Rasmussen, Shefali Chauhan, Guak-Kim Tan, Paige Morrow, Kyle Hanson, Emily Lian, Anthony Haight, Tyuji Hoshino, Xianzhi Liu, Noah Berlow, Charles Keller, Yajun Lian
A Review of Aryl Hydrocarbon Receptor–Mediated Immune Regulation in Cutaneous Squamous Cell Carcinoma Progression
Huiyan Han, Qinyi Dong, Zijian Zhang, Siying Li, Han Zhang, Xinman Wang, Jiahao Bai, Lei Shi, Xiaoyi Fu, Kaili Zheng, Lili Liang
Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer – A Post Hoc Analysis of METIMMOX Trial Data
Sebastian Meltzer, Silje Landmark, Jūratė Šaltytė Benth, Anne Negård, Hanne Mari Hamre, Christian Kersten, Eva Hofsli, Marianne Grønlie Guren, Halfdan Sorbye, Kjersti Flatmark, Anne Ree
Role of Cytokines in Bone Diseases and Their Therapeutic Application
Adrita Guha, Praneet Wahi, Girdhari Lal
Frequently asked questions
How long does it take to publish?
Accelerated Publication.
Reformat to Immunotargets And Therapy using Livewrite PremiumIs a cover letter required?
A point-by-point covering letter is required when submitting a revised manuscript after first editorial review.
Reformat to Immunotargets And Therapy using Livewrite PremiumWhat are the publication costs?
An Article Publishing Charge (APC) may be required for publication. Authors may be able to publish at no cost to themselves or with a reduced APC through institutional or funder agreements, and discounts and waivers may be available for selected countries.
Reformat to Immunotargets And Therapy using Livewrite Premium